Mycophenolatmofetil als effektive Therapieoption bei vernarbendem Pemphigoid

[1]  W. Burgdorf.  Histopathology of blistering diseases: With clinical, electron microscopic, immunological, and molecular biological correlations , 2004 .

[2]  M. Megahed.  Histopathology of Blistering Diseases: With Clinical, Electron Microscopic, Immunological and Molecular Biological Correlations Textbook and Atlas , 2004 .

[3]  K. Yancey,et al.  Anti-Epiligrin Cicatricial Pemphigoid: Clinical Findings, Immunopathogenesis, and Significant Associations , 2003, Medicine.

[4]  E. Bröcker,et al.  Cicatricial pemphigoid with circulating autoantibodies to β4 integrin, bullous pemphigoid 180 and bullous pemphigoid 230 , 2001, The British journal of dermatology.

[5]  J. Colón,et al.  Autoantibodies to Human α6 Integrin in Patients with Oral Pemphigoid , 2001 .

[6]  T. Ruzicka,et al.  Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent. , 2001, Journal of the American Academy of Dermatology.

[7]  T. Olivry,et al.  A spontaneous canine model of mucous membrane (cicatricial) pemphigoid, an autoimmune blistering disease affecting mucosae and mucocutaneous junctions. , 2001, Journal of autoimmunity.

[8]  S. Kumari,et al.  Autoantibodies to human alpha6 integrin in patients with oral pemphigoid. , 2001, Journal of dental research.

[9]  K. Yancey,et al.  Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations. , 2000, JAMA.

[10]  T. Hashimoto,et al.  A Case of Antiepiligrin Cicatricial Pemphigoid Successfully Treated by Plasmapheresis , 2000, Dermatology.

[11]  A. Ahmed,et al.  Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study. , 1999, Ophthalmology.

[12]  D. Orlinsky,et al.  Mycophenolate mofetil in autoimmune and inflammatory skin disorders. , 1999, Journal of the American Academy of Dermatology.

[13]  T. Reinhard,et al.  Mycophenolatmofetil (CellCept®) bei okulären immunologischen Störungen - Literaturübersicht mit 3 Kasuistiken , 1998 .

[14]  A. Enk,et al.  Treatment of pemphigus vulgaris with mycophenolate mofetil , 1997, The Lancet.

[15]  D. Woodley,et al.  Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid. , 1997, The Journal of investigative dermatology.

[16]  T. Luger,et al.  Bullous pemphigoid treated with mycophenolate mofetil , 1997, The Lancet.

[17]  C. Foster,et al.  Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Lipsky.  Mycophenolate mofetil , 1996, The Lancet.

[19]  W. Montgomery,et al.  Management of Airway Obstruction in Cicatricial Pemphigoid , 1996, The Laryngoscope.

[20]  P Fauchald,et al.  PLACEBO-CONTROLLED STUDY OF MYCOPHENOLATE MOFETIL COMBINED WITH CYCLOSPORINE AND CORTICOSTEROIDS FOR PREVENTION OF ACUTE REJECTION , 1995 .

[21]  F. Wojnarowska,et al.  Vulvar involvement in autoimmune bullous diseases. , 1993, The Journal of reproductive medicine.

[22]  C. Foster,et al.  Remission and recurrence after withdrawal of therapy for ocular cicatricial pemphigoid. , 1991, Ophthalmology.

[23]  L. Diaz,et al.  Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. , 1985, Journal of immunology.

[24]  A. Ahmed,et al.  Cicatricial pemphigoid. , 1991, Journal of the American Academy of Dermatology.